Deb Prasad
Analyst
Lucid Capital Markets
Equibles does not estimate personal net worth.
About Deb Prasad
Deb Prasad is recorded as Analyst at Lucid Capital Markets. Deb Prasad has spoken on 2 earnings calls across 2 companies, most recently for Acumen Pharmaceuticals, Inc. on August 12, 2026. Those appearances were for Acumen Pharmaceuticals, Inc. (ABOS) and Palvella Therapeutics, Inc. (PVLA). The companies whose calls Deb Prasad spoke on are classified in the Healthcare sector.
Deb Prasad on recent calls
“First is to follow up on the biomarker data question, will that biomarkers data will be in the top line release or it will follow later? And the second is, what should we expect from September 16 IR Day?”
“I have a, sorry for the progress, I have a couple of quick ones.”
Affiliation history
-
Lucid Capital Markets
Analyst
Transcript header (unverified)
Current